# Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)

> **NCT05695924** · NA · RECRUITING · sponsor: **Fibralign Corporation** · enrollment: 60 (estimated)

## Conditions studied

- Lymphedema
- Edema

## Interventions

- **DEVICE:** BioBridge® Collagen Matrix
- **PROCEDURE:** Vascularized Lymph Node Transfer (VLNT)

## Key facts

- **NCT ID:** NCT05695924
- **Lead sponsor:** Fibralign Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-01
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05695924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05695924, "Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05695924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*